
A suspected cancer diagnosis brings urgent decisions, unfamiliar tests and more questions than one appointment can answer. By the end, you will know what a children’s cancer specialist does from the first consultation through treatment, emergencies, recovery and long-term follow-up—and how to prepare for each stage.
Key takeaways
- Bring symptom dates, medicines, previous reports, and your family history.
- A diagnosis combines examination, blood tests, imaging, and sometimes tissue or marrow testing.
- Ask how results change treatment, expected side effects, and urgent warning signs.
- Follow-up monitors relapse, growth, organ health, immunity, and recovery after transplantation.
What happens from the first worrying symptom to a confirmed diagnosis?
Recognising concerning symptoms does not mean assuming cancer. During the first consultation, the specialist asks when symptoms began, whether they are worsening, the child’s infections and illnesses, medicines, family history, growth, and previous test results. A physical examination looks for findings that support a blood disorder, infection, inflammation, or a benign condition.
The investigation is selected according to the pattern of symptoms:
- A complete blood count checks haemoglobin, white-cell counts and platelets for abnormalities or combinations that need further evaluation.
- A peripheral smear examination lets the laboratory and specialist inspect blood-cell shape, maturity and unusual cells.
- Imaging examines a suspected mass, enlarged lymph nodes, organs, bones, or the chest.
- Bone-marrow aspiration and biopsy assess marrow structure and identify abnormal cells when a blood or marrow disorder is suspected.
- Flow cytometry identifies cell markers that define many leukaemia and lymphoma subtypes.
- Cytogenetic and molecular tests detect chromosome or gene changes that refine the diagnosis and influence treatment.
- Pathology review confirms whether tissue is cancerous and identifies its precise type.
The specialist compares these findings with examination results rather than treating one abnormal test in isolation. Infection can cause fever or altered blood counts, while benign growths can resemble malignant masses on an initial scan. The combined results establish the disease subtype, extent, and risk group, which determine treatment intensity.
How should you prepare for the first specialist consultation?
Bring previous reports, blood-test results, scans, pathology slides or blocks, a medication list, vaccination records, and a dated symptom timeline. Add allergies, previous admissions, treatment already given, and the child’s current weight if known.
The specialist reviews the history and examination, checks which results are missing, and explains whether pathology review, flow cytometry, genetic testing, bone-marrow examination, or lumbar puncture is needed. Dr. Atish Bakane helps families distinguish confirmed findings from questions awaiting results, so an early impression is not mistaken for the final diagnosis. Ask:
- What is the exact disease name and subtype? Is it confirmed?
- What stage or risk group applies, and which test findings determined it?
- Is the treatment objective cure, control, symptom relief, or preparation for transplantation?
- How long will each phase last, and how often will hospital visits be needed?
- What alternatives exist, and what is gained or lost with each?
- Could treatment affect fertility, school, growth, or daily life?
- Which symptoms require an immediate call, and who should you contact after hours?
| Option | What it means | What to clarify |
|---|---|---|
| Chemotherapy or targeted therapy | Medicines treat cancer throughout the body | Drugs, phases, monitoring, and expected response |
| Surgery or radiotherapy | Local treatment removes or controls a tumour | Whether it replaces or follows medicines |
| Transplantation or cellular therapy | Intensive treatment followed by stem-cell or immune-cell support | Donor or cell source, risks, timing, and alternatives |
How do test results shape the treatment plan?
A treatment plan starts with the exact disease subtype and risk group, not the broad label “cancer.” Pathology examines tissue or cells, while flow cytometry identifies cell-surface markers that distinguish blood cancers. Cytogenetic testing finds chromosome changes, and molecular tests detect gene alterations that can predict behaviour or reveal a targeted-treatment option.
Bone-marrow aspiration and biopsy show whether marrow is involved and how normal blood production is affected.
| Disease | Results that matter | Treatment direction |
|---|---|---|
| Leukaemia | Blood and marrow findings, flow cytometry, genetic results, measurable residual disease | Risk-adapted chemotherapy, targeted therapy or immunotherapy, with supportive care and transplant assessment when indicated |
| Lymphoma | Lymph-node pathology, immunophenotype, molecular findings and imaging-defined sites | Chemotherapy, immunotherapy, radiotherapy or surgery for diagnosis and selected complications |
| Solid tumours | Pathology, tumour location, spread on imaging, surgical findings and molecular tests | Surgery when removable, with chemotherapy, radiotherapy or targeted therapy according to risk |
| Non-cancer disorders | Marrow examination, blood tests, flow cytometry and genetic evaluation | Disease-specific medicines, transfusions, infection prevention, supportive care or transplantation |
Imaging shows where disease is and whether it is shrinking; it does not replace pathology. After early treatment, blood or marrow response can intensify or reduce therapy. Measurable residual disease detects abnormal cells below ordinary microscope visibility, helping predict relapse risk and determine whether chemotherapy, immunotherapy, targeted therapy or transplant planning must change.
Supportive care is adjusted alongside disease treatment to protect nutrition, blood counts, pain control and quality of life.
What support does a child and family need during active treatment?
Support during active treatment combines safe treatment delivery with rapid responses to problems. At hospital visits, the team reviews symptoms, medicines, blood counts and examination before deciding on chemotherapy, admission, transfusion or discharge. Ask who to call, which temperature threshold applies, and when the next review is due.
- Learn care of the intravenous device or central venous catheter: hand hygiene, dressing and cap changes, keeping it dry as instructed, checking the site, and responding to a blockage, broken line or pump alarm.
- Review the blood count. Low neutrophils raise infection risk; low platelets cause bleeding; low haemoglobin causes fatigue. The team explains when red-cell or platelet transfusions are needed.
- Follow anti-infection precautions, but treat fever during chemotherapy as an emergency: use the centre’s temperature threshold and contact route instead of giving an antipyretic and waiting.
- Ask about antiemetics, fluids and a dietitian’s plan for nausea, vomiting, dehydration, poor intake and mouth sores (mucositis). Discuss pain relief early.
- Keep a school plan covering attendance, home learning, examinations, contact with classmates and a safe return, based on counts and energy.
- Get urgent instructions for chemotherapy complications, including an allergic reaction, uncontrolled bleeding, severe pain, breathing difficulty, new weakness, seizure, confusion or a tumour-related symptom.
Psychology, social work, child-life and palliative-care teams can support distress, sleep, practical hardship, communication and symptom relief alongside treatment. Leave each visit with written medicines, warning signs and contact numbers.
How does specialist care continue after treatment or transplantation?
Follow-up begins before discharge, with decisions revisited as donor testing, treatment response and the child’s condition change. HLA compatibility helps select an allogeneic donor, while autologous transplantation uses the child’s own collected cells.
| Option | What it means | Main trade-off |
|---|---|---|
| Autologous transplantation | The child’s own stem cells are returned after intensive treatment | No donor-derived graft-versus-host disease, but no donor immune graft-versus-leukaemia effect |
| Allogeneic transplantation | Stem cells come from a matched or suitably compatible donor | Provides a graft-versus-leukaemia effect but risks graft-versus-host disease |
After allogeneic transplantation, report a new rash, diarrhoea, jaundice, dry eyes or mouth, breathing difficulty, or reduced movement promptly; graft-versus-host disease can damage skin, gut, liver, lungs and other organs. Cellular-therapy families need written emergency instructions for fever, breathing difficulty, low blood pressure, confusion or seizures.
Before chemotherapy, radiotherapy, conditioning or selected cellular therapies, ask for fertility counselling; options depend on puberty, sex, urgency and available time. Psychosocial care supports school, sleep, anxiety and caregiver strain, while palliative care can control symptoms and clarify goals alongside treatment.
The written follow-up plan should name appointments, medicines, emergency contacts, vaccinations, blood tests and survivorship screening for growth, hormones, heart, lungs, learning, fertility, second cancers and mental health. It should also state who coordinates care and when each test is due.
Frequently asked questions
What happens from a worrying symptom to a confirmed diagnosis?
The specialist reviews symptoms, medical history, medicines, growth, family history, and previous reports, then examines the child. Blood tests, imaging, tissue sampling, or bone marrow testing may be used to identify the cause.
How should you prepare for the first specialist consultation?
Bring a symptom timeline, medicine list, vaccination and illness history, family history, growth information, previous test reports, and your questions.
How do test results shape the treatment plan?
Results identify the condition, its extent, and features that affect treatment choice. The specialist uses them to discuss options, timing, expected effects, and monitoring.
What support does a child and family need during active treatment?
Support includes symptom and infection monitoring, nutrition, emotional care, school planning, practical coordination, and clear instructions about when to contact the treatment team.
How does specialist care continue after treatment or transplantation?
Follow-up checks for recurrence, treatment effects, growth, development, organ health, immunity, and other recovery needs after cancer treatment or transplantation.






